Analyse
Fundierte Analysen zu Pharmamärkten, Lieferketten, Technologie und Regulierung
Analyse28. Sept. 2026•39 Min. Lesezeit
Building ERP for Pharmaceutical Manufacturing: Challenges, GxP Requirements, System Architecture and Implementation Strategy
From master data and batch lifecycle to validation, change control and system-of-record ownership: why pharmaceutical ERP is harder than generic ERP, where implementations fail, and how a GxP-ready operating model becomes the foundation automation and AI actually need.
14
1
Analyse22. Sept. 2026•26 Min. Lesezeit
Automatisierung und KI entlang der pharmazeutischen Lieferkette: Eine End-to-End-Landkarte
Von Markt- und Portfolioentscheidungen bis zu Apotheken und Pharmakovigilanz — was regelbasierte Automatisierung bereits leistet, wo KI Mehrwert schafft und welche Entscheidungen bei verantwortlichen Personen bleiben müssen.
211
2
Analyse
28. Sept. 2026•1 Min. Lesezeit
Pharma distributors set delivery cut‑offs ahead of Chuseok holiday (Sep 21‑23)
South Korean pharmaceutical distributors announce order cut‑off dates of Sep 21‑23 before the Chuseok holiday, with shipments resuming on Sep 28.
4
Analyse
28. Sept. 2026•1 Min. Lesezeit
South Korea Summer OTC Market Shows Diverging Trends; Acne Treatment Azelia Enters Top 10
Summer pharmacy OTC sales in South Korea displayed mixed movements, with acne drug Azelia rising sharply into the top‑10, while vitamin brands showed varied growth.
2
Analyse
28. Sept. 2026•1 Min. Lesezeit
GSK’s Duac Gel 5% Faces Ongoing Stock Shortage, Resupply Date Unclear
GSK reports its acne treatment Duac Gel 5% remains out of stock with no confirmed resupply timeline, urging pharmacies to monitor inventory.
1
Analyse
27. Sept. 2026•1 Min. Lesezeit
Mounjaro Leads Surge in Korean Obesity Drug Market, Wegovy Falls to 5th
Mounjaro drove over 30% growth in Korea's obesity treatment market in two months, while Wegovy sales fell for two consecutive months, dropping to fifth place.
Analyse
24. Sept. 2026•1 Min. Lesezeit
Oseltamivir Suspension Powder Faces Supply Shortage Amid Rapid Flu Spread in Korea
Pharmacies report stockouts of pediatric oseltamivir suspension powder as influenza cases surge; some manufacturers still hold inventory, but supply pressure is rising.
Analyse
24. Sept. 2026•1 Min. Lesezeit
Galderma Korea Unveils "Injectable Renaissance" Strategy at GAIN RESTAGE Event
Galderma Korea presented a new aesthetic portfolio—including fillers, biostimulators and skincare—at the GAIN RESTAGE event in Seoul, targeting natural, personalized results.
Analyse
23. Sept. 2026•1 Min. Lesezeit
BaroPharm Expands Pharmacy Beauty Zones to 200 Locations, Aims for 1,000 by Year-End
BaroPharm's Pharmacy Beauty Zone reaches 200 outlets within a month, targeting 1,000 pharmacies nationwide by year‑end.
Analyse
23. Sept. 2026•1 Min. Lesezeit
Musinsa Beauty teams with Onnuri Pharmacy for first offline store in Seoul
Musinsa Beauty and the Onnuri pharmacy chain opened their first joint offline store in Hongdae, merging K‑beauty products with pharmacy‑grade cosmetics and skin‑care medicines.
1
Analyse
23. Sept. 2026•1 Min. Lesezeit
Samsung Biologics Secures ~KRW 3.5tn CMO Deal with European Pharma
Samsung Biologics announced a new CMO contract worth about KRW 3.5 trillion (~US$262 million) with a European pharmaceutical company, running until Dec 31 2033.
Analyse
22. Sept. 2026•1 Min. Lesezeit
Jongkundang's Zitec GI drug pushes for reimbursement as insurer weighs clinical and industrial value
Jongkundang is working to secure reimbursement for its domestically developed GI medication Zitec, with the National Health Insurance Service evaluating its clinical usefulness, industrial value, alternative drug pricing, and fiscal impact.